Home > Insider Trading > Filing (0001192482-17-000282)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640701	B Alison Fleming	C/O Collegium Pharmaceutical, Inc. 780 Dedham Street, Suite 800 Canton MA 02021	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-17	1,950	$0.28	28,513	No	4	M	Direct
Common Stock	Disposition	2017-11-17	1,950	$17.00	26,563	No	4	S	Direct
Common Stock	Acquisiton	2017-11-17	1,239	$0.28	27,802	No	4	M	Direct
Common Stock	Disposition	2017-11-17	1,239	$17.00	26,563	No	4	S	Direct
Common Stock	Disposition	2017-11-17	840	$17.00	25,723	No	4	S	Direct
Common Stock	Acquisiton	2017-11-21	572	$0.28	26,295	No	4	M	Direct
Common Stock	Disposition	2017-11-21	572	$19.00	25,723	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to purchase)	Disposition	2017-11-17	1,950	$0.00	1,950	$0.28
Common Stock	Stock option (right to purchase)	Disposition	2017-11-17	1,239	$0.00	1,239	$0.28
Common Stock	Stock option (right to purchase)	Disposition	2017-11-21	572	$0.00	572	$0.28

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,225	2024-03-05	No	4	M	Direct
4,489	2024-03-05	No	4	M	Direct
3,917	2024-03-05	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
2,600 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vests and becomes exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer.
2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.